Close

Increasing Access to Point-of-Care Diagnostics Through Innovative Advances in Molecular Reagents for Assay Development

20 November 2024

ON DEMAND

Despite gaining traction in diagnostics, molecular Point-of-Care (POC) tests face challenges related to accessibility, stability, and ease of workflow.

Due to infrastructure limitations, especially in remote areas, there is often a lack of necessary resources for appropriately storing reagents, and complex workflows are frequently difficult to implement in non-laboratory settings.

VIEW THIS WEBINAR TO LEARN ABOUT:
• Innovative molecular reagents that simplify assay workflow using direct detection
• Benefits to eliminating cold-chain through ambient temperature assay stability
• Advances in qPCR and isothermal technologies tailored for point-of-care use

Don’t miss this opportunity to gain valuable insights from experts in molecular reagent development.

About the Speaker

Lina is an R&D Team Leader at Meridian Bioscience, creating innovative solutions for the diagnostic industry. Previously, as a co-founder and the Director of Science at Biotangents, a veterinary diagnostics company based in Scotland, she spent seven years guiding the development and refinement of molecular diagnostic tests. These tests were designed for a range of diverse settings, from laboratory use to point-of-need applications, requiring robust reagent transport and storage solutions. Earlier in her career, Lina worked in metabolic engineering within the synthetic biology industry striving for more sustainable materials production and researched cancer biomarkers, building on her academic foundation in Molecular Biology and Biotechnology.

<b>Lina Gasiūnaitė, Team Leader R&D</b></br>Molecular, Life Science
Lina Gasiūnaitė, Team Leader R&D
Molecular, Life Science

Get In Touch With A Specialist

Welcome to
logo blue

Please select your country to continue

Continue
CN